Early Santa Claus Rally Highlights Power Nickel Inc. (TSXV: PNPN) and Other Stocks to Watch Now!

Power Nickel Inc. (TSXV: PNPN) (OTCQB: PNPNF) reached a new 52-week high of $0.98 CAD intraday on Wednesday, driven by groundbreaking results from its fall drilling campaign at the Nisk Project near Nemaska, Quebec. Recent assay results from drill hole PN-24-078 underscore the polymetallic potential of the site, with highlights including:

* 9.40 m grading 0.53 g/t Au, 11.95 g/t Ag, 1.15% Cu, 1.08 g/t Pd, 0.36 g/t Pt, and 0.06% Ni.
* 11.55 m grading 0.44 g/t Au, 11.55 g/t Ag, 0.59% Cu, 1.25 g/t Pd, 0.76 g/t Pt, and 0.02% Ni.

These results solidify Nisk's standing as a potential leader in polymetallic exploration. [https://finance.yahoo.com/news/power-nickel-hole-78-delivers-135900071.html]

Australia Publication (Mining.com.au) Highlights Power Nickel's Lion Zone as Flagship Discovery: Power Nickel (TSXV: PNPN) has spotlighted the Lion Zone within its Nisk Project in Quebec, Canada, as a crown jewel in polymetallic exploration. The Lion Zone features high-grade deposits, including copper up to 8%, platinum group metals exceeding 22 g/t, gold over 1.6 g/t, and silver surpassing 69 g/t.

As part of its 2025 winter exploration program, Power Nickel plans to drill westward, extend eastward, and explore at depth, utilizing downhole electromagnetic (EM) surveys for targeted deeper drilling. The company aims to complete 30,000 meters of drilling by April 2025 and 50,000 meters by year-end. Additionally, a metallurgical study is slated for H2 2025, underscoring the company's commitment to advancing its flagship project and maximizing shareholder value. [https://buff.ly/4gD3nHL].

Hannam & Partners, in its latest report, reaffirmed a $1.70 CAD target valuation for Power Nickel, citing the Lion Zone's growing dimensions and resource potential. Drill holes 93 and 95A have confirmed mineralization at depth and along strike, extending the mineralized structure to at least 600 meters. Hannam's base case projects a provisional resource of 15.2Mt containing 835kt CuEq, with potential upside exceeding US$1 billion if further extensions materialize.

Power Nickel's momentum reflects its commitment to advancing polymetallic exploration in Quebec's resource-rich landscape. As one of the most compelling base metal discoveries globally in recent years, the Nisk Project continues to attract attention from both retail and institutional investors. With its strategic initiatives and robust results, Power Nickel is poised to redefine the future of polymetallic mining in Canada. [https://thestreetreports.com/wp-content/uploads/2024/12/PNPN.V-Report.pdf]

And This Just In: Cadrenal Therapeutics, Inc. (Nasdaq: CVKD) has been named the 2024 "Anticoagulation Therapy Company of the Year" by Pharma Tech Outlook for its groundbreaking development of tecarfarin, a next-generation vitamin K antagonist anticoagulant designed to provide safer treatment for patients with implanted cardiac devices and rare cardiovascular conditions. The company has also announced its participation in key events during the 43rd Annual J.P. Morgan Healthcare Conference Week, set for January 2025.

See other stocks participating in the early Santa Claus rally below:

* Bio-Path Holdings (NASDAQ: BPTH): Announced promising preclinical results for BP1001-A, showcasing enhanced insulin sensitivity and its potential as a treatment for obesity and Type 2 diabetes.
* AppTech Payments Corp. (NASDAQ: APCX): Secured a $5 million equity investment from AFIOS Partners, with potential for an additional $14 million from warrant exercises, and appointed three new Board members to drive strategic growth.
* PainReform Ltd. (NASDAQ: PRFX): Experiencing a significant surge ahead of its upcoming financial results, expected later this month, as originally highlighted by The Street Reports on November 19, 2024. [https://thestreetreports.com/stocks-under-1-to-watch-soars-turnaround-bttcs-energy-surge-prfxs-pain-relief-breakthrough-and-more/]
* Elevai Labs Inc. (Nasdaq: ELAB): Announced its FDA regulatory pathway for EL-22, a first-in-class obesity therapy targeting fat loss while preserving muscle mass. An Investigational New Drug (IND) application is planned for 2025, following a pre-IND meeting early next year, as reported by The Street Reports on November 5, 2024.
* RJD Green Inc. (OTC: RJDG): Reported FY24 revenue of $5.7M and $894K net income, while outlining bold 2025 growth plans in healthcare, environmental, and construction sectors, including JSI Products Corporation's expansion across four states. Featured in news articles on November 5, 2004 and November 19, 2024, RJD Green remains a stock to watch.

These companies have demonstrated significant momentum and present compelling opportunities for investors heading into 2025. Keep an eye on these early rally participants as they continue to shape their respective sectors.

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=early-santa-claus-rally-highlights-power-nickel-inc-tsxv-pnpn-and-other-stocks-to-watch-now]
Country: United States
Website: http://www.thestreetreports.com



This release was published on openPR.